शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEABATE AS INDUSTRIES LIMITED· Healthcare ServicesHighNeutral
Announced Thu, 13 Aug, 2026 · 16:41 IST

Q1 FY27 results: consolidated revenue down 44% YoY; PAT flat, board okays healthcare push

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.8%Reaction day
₹9.00
prior close
₹8.97
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+3.7% vs market
Hospital peers, median of 25sector+0.3%+3.5% vs sector

On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.2
15m
+0.3
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.8+0.1+3.7+0.3+3.5
Next day
-1.1+0.2-1.3-0.2-0.9
2d
-0.2+0.6-0.8-0.3+0.1
3d
+0.7-0.0+0.7-0.2+0.9
4d
+3.8+0.5+3.3-0.3+4.1
5d
+3.0+0.8+2.2-1.1+4.1
1w
+1.9+0.6+1.3-0.2+2.1
15d
+0.0+1.3-1.3+0.1-0.1
1m
-6.8-1.4-5.4-1.3-5.5
2m
-15.6-0.6-15.0-9.4-6.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 (ended 30 June 2026): standalone revenue fell to Rs 25.05 lakh from Rs 40 lakh YoY; PAT Rs 14.31 lakh. Consolidated revenue dropped 44% to Rs 2,307.29 lakh from Rs 4,147.91 lakh; PAT flat at Rs 224.34 lakh. EPS Rs 0.01 standalone and Rs 0.08 consolidated. Board approved expanding objects clause into healthcare, hospitals, medical devices. One new independent director appointed, three re-appointed for 5 years. 35th AGM on 16 September 2026.

Likely market impact

Sharp revenue decline signals a weak quarter; healthcare expansion plan could be a long-term positive but adds execution risk.